Unknown

Dataset Information

0

N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes.


ABSTRACT: We carried out a secondary analysis in high-risk patients with a previous myocardial infarction (MI) and diabetes in the Alpha Omega Trial. We tested the hypothesis that in these patients an increased intake of the n-3 fatty acids eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and ?-linolenic acid (ALA) will reduce the incidence of ventricular arrhythmias and fatal MI.A subgroup of 1,014 post-MI patients with diabetes aged 60-80 years was randomly allocated to receive one of four trial margarines, three with an additional amount of n-3 fatty acids and one placebo for 40 months. The end points were ventricular arrhythmia-related events and fatal MI. The data were analyzed according to the intention-to-treat principle, using multivariable Cox proportional hazards models.The patients consumed on average 18.6 g of margarine per day, which resulted in an additional intake of 223 mg EPA plus 149 mg DHA and/or 1.9 g ALA in the active treatment groups. During follow-up, 29 patients developed a ventricular arrhythmia-related events and 27 had a fatal MI. Compared with placebo patients, the EPA-DHA plus ALA group experienced less ventricular arrhythmia-related events (hazard ratio 0.16; 95% CI 0.04-0.69). These n-3 fatty acids also reduced the combined end-point ventricular arrhythmia-related events and fatal MI (0.28; 0.11-0.71).Our results suggest that low-dose supplementation of n-3 fatty acids exerts a protective effect against ventricular arrhythmia-related events in post-MI patients with diabetes.

SUBMITTER: Kromhout D 

PROVIDER: S-EPMC3220851 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes.

Kromhout Daan D   Geleijnse Johanna M JM   de Goede Janette J   Oude Griep Linda M LM   Mulder Barbara J M BJ   de Boer Menko-Jan MJ   Deckers Jaap W JW   Boersma Eric E   Zock Peter L PL   Giltay Erik J EJ  

Diabetes care 20111201 12


<h4>Objective</h4>We carried out a secondary analysis in high-risk patients with a previous myocardial infarction (MI) and diabetes in the Alpha Omega Trial. We tested the hypothesis that in these patients an increased intake of the n-3 fatty acids eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and α-linolenic acid (ALA) will reduce the incidence of ventricular arrhythmias and fatal MI.<h4>Research design and methods</h4>A subgroup of 1,014 post-MI patients with diabetes aged 60-80 yea  ...[more]

Similar Datasets

| S-EPMC2655314 | biostudies-literature
2024-01-26 | PXD041535 | Pride
| S-EPMC6474949 | biostudies-literature
| S-EPMC5521775 | biostudies-literature
| S-EPMC9743565 | biostudies-literature
| S-EPMC8416412 | biostudies-literature
| S-EPMC10715678 | biostudies-literature
| S-EPMC6479517 | biostudies-literature
| S-EPMC5538863 | biostudies-other